Logo

Paradigm Genetics Wins $12M Venture Financing

Dec 18, 1998
Premium

RESEARCH TRIANGLE PARK, NC--Paradigm Genetics, founded here in September 1997 by four former Novartis Crop Protection managers, closed its first round of financing with a $6 million preferred-stock equity offering and $6 million in venture lease financing. The agricultural biotechnology company said it will develop new products and pursue collaborations with major agriculture and chemical companies. Investors included Intersouth Partners of Durham, NC; Polaris Venture Partners of Boston; and the Innotech Investments, based in the UK.

Filed under

Informatics
Breaking News
The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.